During Market hours on Friday – 19.11.2021:
- The Dow (Symbol: DIA) went down 0.96%. The S&P 500 (Symbol: SPY) lost 0.18% and the Nasdaq (Symbol: QQQ) rose 0.56%.
- United Airlines (Symbol: UAL), Boeing (Symbol: BA) — Shares of travel-related stocks dipped after Austria announced earlier in the day that it would reenter a full national lockdown due to a spike in Covid cases. United Airlines fell 2.8% while American (Symbol: AAL) dipped 0.6%. Boeing fell 5.8%.
- Devon Energy (Symbol: DVN) , Hess Corporation (Symbol: HES) – The exploration and production companies slid more than 5%, leading the broader energy sector lower, amid a drop in oil prices. Every component in the S&P 500 energy sector traded in the red on Friday, with oil on track for its fourth straight week of losses.
- Robinhood (Symbol: HOOD) — Shares of the brokerage fell 5% after Deutsche Bank said it expects Robinhood’s customer accounts and assets will drop again in the fourth quarter and growth will continue to slow into 2022. For that reason, Robinhood is Deutsche Bank’s new “sell idea”.
- Moderna (Symbol: MRNA) — Shares of Moderna jumped 4.9% after the Food and Drug Administration authorized Moderna and Pfizer’s Covid vaccine booster shots for all U.S. adults. Pfizer (Symbol: PFE) shares were higher earlier in the session but closed 1.2% lower.
- Applied Materials (Symbol: AMAT) — Shares of Applied Materials retreated 5.5% after the semiconductor equipment maker missed on quarterly earnings estimates. The company reported adjusted quarterly earnings of $1.94 per share, one cent shy of expectations, and posted revenue below Wall Street projections. Applied Materials also gave a weaker-than-expected current-quarter outlook citing supply shortages.
- Ross Stores (Symbol: ROST) — Ross Stores shares dipped 5.6% despite an earnings beat. The off-price retailer posted quarterly earnings of $1.09 per share, beating the 78-cent Refinitiv consensus estimate. However, the discount retailer said it was seeing significant supply chain issues and uncertainty heading into the holiday shopping season.
- Workday (Symbol: WDAY) — Workday shares fell 4.2% despite the software company’s better-than-expected earnings report. The company posted earnings of $1.10 per share, 24 cents better than the Refinitiv consensus estimate. Workday said the effects of the Covid-19 pandemic will weigh on growth in the coming year.
- Buckle (Symbol: BKE) — Buckle saw its shares retreat 6.5% despite beating Wall Street estimates in its quarterly earnings report. The fashion retailer earned $1.26 per share for the quarter, beating the 92-cent Refinitiv consensus estimate.
- Intuit (Symbol: INTU) — The business software stock jumped 10.1% after strong growth in online accounting revenue fueled a beat on the top and bottom lines for Intuit’s fiscal first quarter. The company reported adjusted earnings of $1.53 per share on $2.01 billion in revenue. Analysts surveyed by Refinitiv had penciled in 97 cents in earnings per share and $1.81 billion of revenue.
During Premarket hours today (Monday – 22.11.2021):
- Astra Space (Symbol: ASTR) — Astra rocketed 38.4% higher in premarket trading, after Astra sent a rocket into orbit for the first time over the weekend. The rocket carried a U.S. Space Force payload.
- Activision Blizzard (Symbol: ATVI) — Activision CEO Bobby Kotick would consider leaving his job if he cannot fix culture problems at the video game maker, according to a Wall Street Journal report. Kotick is said to have made those comments to senior managers after he and the company faced criticism for its handling of sexual misconduct allegations. Activision shares slid 1.4% in premarket trading.
- Apple (Symbol: AAPL) — Apple will not be able to deliver new iPads in time for Christmas in key Asian markets, according to Japan’s Nikkei news service. The report also said iPhone delivery delays aren’t quite as long, but still far longer than in a typical year.
- Pfizer (Symbol: PFE), BioNTech (Symbol: BNTX), Moderna (Symbol: MRNA) — The drugmakers saw their shares rise after Covid booster shots for all adults got final clearance from the Centers for Disease Control and Prevention on Friday. Additionally, Pfizer and BioNTech announced upbeat study results for vaccine recipients aged 12-15. BioNTech was up 2% while Moderna gained 1.8%. Pfizer edged higher by 0.8%.
- Monster Beverage (Symbol: MNST) — The energy drink maker is discussing a merger with Constellation Brands (Symbol: STZ), according to multiple reports. Bloomberg – which first reported those talks – said the structure of such a deal is not yet known. Monster Beverage and the spirits producer have a combined market value of nearly $92 billion. Constellation rose 2% in the premarket, while Monster was down 0.3%.
- Vonage (Symbol: VG) — Ericsson (Symbol: ERIC) is buying the U.S. cloud communications firm for $6.2 billion, with the deal expected to close in the first half of next year. The deal follows the Swedish telecom firm’s acquisition of U.S. wireless networking company Cradlepoint last year for $1.1 billion. Vonage soared 25.7% in the premarket, while Ericsson slid 4%.
- Bluebird Bio (Symbol: BLUE) — The drugmaker’s shares surged 8% in the premarket after the Food and Drug Administration granted priority review status for its treatment of a blood disorder known as thalassemia.
- Rivian (Symbol: RIVN) — Rivian fell more than 4% in premarket trading following Friday’s news that Ford (F) and Rivian have dropped plans to jointly develop an electric vehicle.
- Wynn Resorts (Symbol: WYNN) — Wynn added 1.4% in the premarket, while Melco Resorts (Symbol: MLCO) gained 1.6%. Both resort operators rose on a South China Morning Post report that the border between Hong Kong and mainland China could reopen soon, potentially increasing the number of visitors to Macau casinos.
- Blink Charging (Symbol: BLNK) — The stock was downgraded to “market perform” from “outperform” at Cowen, which said the charging network operator’s valuation is stretched following a “euphoric” run across electric vehicle charging stocks. Blink lost 2.6% in premarket action.
*Any information contained in this article, including any information contained in external third party links, if any, is solely for informational purposes and does not contain, or should not be construed as containing, investment advice or an investment recommendation, or, an offer of or solicitation for any transactions in financial instruments. Past performance does not guarantee or predict future performance. Colmex Pro Ltd does not take into account your personal investment objectives or financial situation and makes no representation, and assumes no liability to the accuracy or completeness of the information provided, nor for any loss arising from any investment based on presented information.